Cervical cancer screening and updated Pap guidelines

Cervical cancer and its dysplasia precursors account for significant morbidity and mortality in women worldwide. Human papillomavirus infection is common, preventable, and now widely accepted as the causative agent with oncogenic potential in the development of cervical cancer. Screening via Papanic...

Full description

Saved in:
Bibliographic Details
Published inPrimary care Vol. 36; no. 1; p. 131
Main Authors Warren, Johanna B, Gullett, Heidi, King, Valerie J
Format Journal Article
LanguageEnglish
Published United States 01.03.2009
Subjects
Algorithms
Cervical Intraepithelial Neoplasia - diagnosis
Cervical Intraepithelial Neoplasia - epidemiology
Cervical Intraepithelial Neoplasia - etiology
Female
Humans
Mass Screening
Papanicolaou Test
Papillomavirus Infections - complications
Papillomavirus Infections - epidemiology
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines
Practice Guidelines as Topic
United States - epidemiology
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - epidemiology
Uterine Cervical Neoplasms - etiology
Vaginal Smears
Women's Health
United States
Online AccessGet more information

Cover

More Information
Summary:Cervical cancer and its dysplasia precursors account for significant morbidity and mortality in women worldwide. Human papillomavirus infection is common, preventable, and now widely accepted as the causative agent with oncogenic potential in the development of cervical cancer. Screening via Papanicolaou testing is critical, and interpretation of test results with knowledge of patient risk factors is imperative. Many evidence-based guidelines for screening, interpretation, and management have been developed and are widely available for use.
ISSN:1558-299X
DOI:10.1016/j.pop.2008.10.008